An immune-related gene pair signature predicts the prognosis and immunotherapeutic response in glioblastoma
The IRGP signature was built to predict the prognosis of GBM patients. This signature can serve as a tool to predict the response to immunotherapy in GBM.
Authors
- Chuncheng Hao (ORCID: https://orcid.org/0000-0002-5447-3642)
- Yingchun Man
- Lihong Zhao (ORCID: https://orcid.org/0000-0002-8565-1333)
- Lixin Lun
- Kui Cao (ORCID: https://orcid.org/0000-0002-6769-5121)
- Yiyang Chen (ORCID: https://orcid.org/0000-0001-9960-9040)
- Lijie Zhang (ORCID: https://orcid.org/0000-0002-9435-9799)
- Gang Wang (ORCID: https://orcid.org/0000-0001-6500-5863)
- Xueying Wang (ORCID: https://orcid.org/0000-0001-9291-793X)
- Xinyu Zhao (ORCID: https://orcid.org/0000-0002-5128-4424)
Institutions
- Harbin Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e39025
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.44